Blood cancer

Israeli doctors use patients' own cells to attack blood cancer cells in medical breakthrough

The first three patients to undergo the procedure did so without complication and were discharged as planned, Rabin Medical Center announced.

Dr Yarden Shor Nareznoy , Scientist of the Samueli Institute and Maya Avraham Hayun, QA Manager at the Samueli Institute
 An Israeli is seen getting a tattoo to commemorate the October 7 massacre.

Possible correlation discovered between tattoos and lymphoma – Swedish study

Israeli researchers develop promising new blood cancer treatment

Harvesting potatoes on the Salad Trail Tour in the Besor region

Can vegetables help treat cancer? - study


Blood Cancer Awareness Month: Exploring innovative treatments

Dr. Martin Ellis, Chairman of the Israel Society of Hematology and Transfusion Medicine, spoke to The Jerusalem Post about two newer treatments for the main types of blood cancer.

Cancer cells [illustrative]

Groundbreaking Israeli treatment may offer cure for blood cancer

“We are reprogramming another type of the immune system’s cells called T-cells, in order to teach them to fight the cancer inside the blood of the patient.”

Two genetically engineered T Cells (light green) attacking a cancer cell in red.

Cell therapy co. Gamida Cell announces USD 75 m. financing

Gamida Cell is a cell therapy company working to develop and commercialize cures for blood cancers and blood diseases.

CEO of Gamida Cell Dr. Julian Adams

How Magen David Adom is protecting Israel's blood supply?

American donors to Magen David Adom are building a new blood center for Israel to ensure there’s blood for civilians and soldiers when it’s needed most.

When completed, Magen David Adom’s new Marcus National Blood Services Center will more than double Israel’s blood-processing capacity

Israeli-American Gamida hits goal in phase 3 blood cancer trial

The company uses umbilical cord blood, which like bone marrow and peripheral blood, is a rich source of stem cells for transplantation.

Red blood cells (illustrative)

Israeli blood cancer treatment could also kill solid tumors - new study

Lead researcher Dr. Yaron Carmi believes that the treatment will be available within two years for human trials and compassionate use.

Tel Aviv University researchers (from left): Dr. Yaron Carmi, Diana Rasuluniriana, Dr. Peleg Ride